Stentless aortic valve replacement: An update

Vascular Health and Risk Management

Volumn 7, Issue 1, 2011, Pages 345-351

  Kobayashi, Junjiro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiopulmonary bypass; Follow up studies; Heart disease; Surgery; Valves

Indexed keywords

AORTA VALVE; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; HUMAN; INSTRUMENTATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PROSTHESIS; REVIEW; TIME; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AORTIC VALVE; BIOPROSTHESIS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 80055082313     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S11253     Document Type: Review

References (77)

1. Ross DN. Aortic valve replacement. Lancet. 1966;27:461-463.
2. Barrat-Boyes BG. Homograft aortic replacement in aortic incompetence and stenosis. Thorax. 1964;19:131-150.
3. Binet JP, Duran CCT, Carpentier A, et al. Heterologous aortic valve transplantation. Lancet. 1965;2:1275-1276.
4. Kon ND, Westaby S, Amarasena N, et al. Comparison of implant techniques using the Freestyle stentless porcine aortic valve. Ann Thorac Surg. 1995;59:857-862.
5. Bortolotti U, Scioti G, Milano A, et al. The Edwards Prima stentless valve: hemodynamic performance at one year. Ann Thorac Surg. 1999; 68:2147-2151.
6. David TE, Rpochan GC, Butany JW. Aortic valve replacement with stentless porcine bioprosthesis. J Cardiac Surg. 1988;3:501-505.
7. O'Brien MF. Implantation technique of the CryoLife-O'Brien stentless xenograft aortic valve: the simple, rapid, and correct way to implant and errors to avoid. Semin Thorac Cardiovasc Surg. 1999;11 (Suppl 1):121-125.
8. Myken PS, Caidahl K, Larsson S, et al. 10-year experience with the Biocor porcine bioprosthesis in the aortic position. J Heart Valve Dis. 1994;3:648-656.
9. Musci M, Siniawski H, Pasic M, et al. Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis. Eur J Cardio Thorac Surg. 2008;34:410-417.
10. D'Onofrio A, Auriemma S, Magagna P, et al. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients. J Thorac Cardiovasc Surg. 2007;134: 491-495.
11. Doss M, Martens S, Wood JP, et al. Aortic leaflet replacement with the new 3F stentless bioprosthesis. Ann Thorac Surg. 2005;79:682-685.
12. Thomas M, Schymic G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
13. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve ReValving system: results from the multicenter, expanded evaluation registry. 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
14. Martens S, Ploss A, Sirat S, et al. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg. 2009;87: 1914-1917.
15. Breitenbach I, Wimmer-Greinecker G, Bockeria LA, et al. Sutureless aortic valve replacement with the Trilogy aortic valve system: multicenter experience. J Thorac Cardiovasc Surg. 2010;140:878-884.
16. Gulbins H, Reichenspurner H. Which patients benefit from stentless aortic valve replacement? Ann Thorac Surg. 2009;88:2061-2068.
17. Luciani GB, Casali G, Auriemma S, et al. Survival after stentless and stented xenograft aortic valve replacement: a concurrent, controlled trial. Ann Thorac Surg. 2002;74:1443-1449.
18. Vrandecic M, Fantini FA, Filho BG, et al. Retrospective clinical analysis of stented vs stentless porcine aortic bioprosthesies. Eur J Cardio Thorac Surg. 2000;18:46-53.
19. Ali A, Halstead JC, Cafferty F, et al. Are stentless valves superior to modern stented valves? A prospective randomized trial. Circulation. 2006;114(Suppl I):I535-I540.
20. Chambers JB, Rimington HM, Hodson F, et al. The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg. 2006;131: 878-882.
21. Dunning J, Graham RJ, Thambyrajah J, et al. Stentless vs stented aortic valve bioprostheses: a prospective randomized controlled trial. Eur Heart J. 2007;28:2369-2374.
22. Deleuze PH, Fromes Y, Khoung W, et al. Eight-year results of Freestyle stentless bioprosthesis in the aortic position: a single center study of 500 patients. J Heart Valve Dis. 2006;15:247-252.
23. Bach DS, Kon ND, Dumesnil, et al. Ten-year outcome after aortic valve replacement with the Freestyle stentless bioprosthesis. Ann Thorac Surg. 2005;80:480-486.
24. David TE, Feindel CM, Bos J, et al. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg. 2008;135:19-24.
25. Jin XY, Ratnatunga C, Pillai R. Performance of Edwards Prima stentless aortic valve over eight years. Semin Thorac Cardiovasc Surg. 2001;13 (Suppl 1):163-167.
26. Dellegren G, Eriksson MJ, Brodin LA, et al. Eleven years' experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardio Thorac Surg. 2002;22:912-921.
27. Polvani G, Barili F, Dainese L, et al. Long-term results after aortic valve replacement with the Bravo 400 stentless valve. Ann Thorac Surg. 2005;80:495-501.
28. O'Brien MF, Gardner MAH, Garlick B, et al. CryoLife-O'Brien stentless valve: 10-year results of 402 implants. Ann Thorac Surg. 2005;79: 757-766.
29. Musci M, Siniawski H, Pasic M, et al. Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients with the Shelhigh stentless bioprosthesis. Eur J Cardio Thorac Surg. 2008;34:410-417.
30. D'Onofrio A, Auriemma S, Magagna P, et al. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients. J Thorac Cardiovasc Surg. 2007;134:491-495.
31. David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg. 1998;116:236-241.
32. Van Nooten, Caes F, François K, et al. Stentless or stented aortic valve implants in elderly patients? Eur J Cardio Thorac Surg. 1999;15: 31-36.
33. Vrandecic M, Fantini FA, Filho BG, et al. Retrospective clinical analysis of stented vs stentless porcine aortic bioprostheses. Eur J Cardio Thorac Surg. 2000;18:46-53.
34. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg. 2000;70:785-791.
35. Luciani GB, Auriemma S, Santini F, et al. Comparison of late outcome after stentless versus stented xenograft aortic valve replacement. Semin Thorac Cardiovasc Surg. 2001;13(Suppl I):I136-I142.
36. Tamin M, Bove T, Van Belleghem Y, et al. Stentless vs stented aortic valve replacement: left ventricular mass regression. Asian Cardiovasc Thorac Ann. 2005;13:112-118.
37. Borger MA, Carson SM, Ivanov J, et al. Stentless aortic valve are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study. Ann Thorac Surg. 2005:80:2180-2185.
38. Bové T, Bellenghem YV, François K, et al. Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcomes. Eur J Cardio Thorac Surg. 2006;30: 706-715.
39. Lehmann S, Walther T, Kempfert J, et al. Stentless versus conventional xenograft aortic valve replacement: midterm results of a prospectively randomized trial. Ann Thorac Surg. 2007;84:467-472.
40. Cohen G, Zagorski B, Christakis GT, et al. Are stentless valves hemodynamically superior to stented valves? Long-term follow up of a randomized trial comparing Carpentier-Edwards pericardial valve with Toronto stentless porcine valves. J Thorac Cardiovasc Surg. 2010;139: 848-859.
41. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
42. He GW, Grunkemeier GL, Gately HL, et al. Up to thirty year survival after aortic valve replacement in small aortic root. Ann Thorac Surg. 1995;59:1056-1062.
43. Cohen G, Christakis GT, Joyner CD, et al. Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg. 2002;73:767-775.
44. Fries R, Wendler O, Schieffer H, et al. Comparative rest and exercise hemodynamics of 23-mm stentless versus 23-mm stented aortic bioprostheses. Ann Thorac Surg. 2000;69:817-822.
45. Morsy S, Zahran M, Usama M, et al. Hemodynamic performance of stentless porcine bioprosthesis and mechanical bileaflet prosthesis using dobutamine stress echocardiography. Semin Thorac Cardiovasc Surg. 2001;13(Suppl I):I129-I135.
46. Bevilacqua S, Gianetti J, Ripoli A. Aortic valve disease with severe ventricular dysfunction: stentless valve for better recovery. Ann Thorac Surg. 2002;74:2016-2021.
47. Totaro P, Degno N, Zeidi A, et al. Carpentier-Edwards Perimount magna bioprosthesis: a stented valve with a stentless performance? J Thorac Cardiovasc Surg. 2005;130:1668-1674.
48. Ali A, Halstead JC, Cafferty F. Early clinical and hemodynamic outcomes after stented and stentless aortic valve replacement: results from a randomized controlled trial. Ann Thorac Surg. 2007;83: 2162-2168.
49. Gulbins H, Florath I, Ennker J. Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period. Ann Thorac Surg. 2009;86:769-773.
50. Del Rizzo DF, Abdoh A, Cartier P, et al. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg. 1999;11(Suppl I):I114-I120.
51. Del Rizzo DF, Freed D, Abdoh A, et al. Mid-term results of stented versus stentless valves: does concomitant coronary artery bypass grafting impact survival? Semin Thorac Cardiovasc Surg. 2001;13 (Suppl I):148-155.
52. Kunadian B, Vijayalakshmi K, Thornley AR, et al. Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann Thorac Surg. 2007;84:73-78.
53. Thomson HL, O'Brien MF, Almeida AA, et al. Haemodynamics and left ventricular mass regression: a comparison of the stentless, stented and mechanical aortic valve replacement. Eur J Cardio Thorac Surg. 1998;13:572-575.
54. Walther T, Falk V, Langebartels G, et al. Regression of left ventricular hypertrophy after stentless versus conventional aortic valve replacement. Semin Thorac Cardiovasc Surg. 1999;11(Suppl I):I18-I21.
55. Maselli D, Pizio R, Bruno LP, et al. Left ventricular mass reduction after aortic valve replacement: homografts, stentless and stented valves. Ann Thorac Surg. 1999;67:966-971.
56. Deeb GM, Smolens IA, Bolling SF, et al. Reoperation for Freestyle stentless aortic valves. Semin Thorac Cardiovasc Surg. 2001;13 (Suppl I):I16-I23.
57. Arenaza DP, Lees B, Flather M, et al. ASSERT (Aortic Stentless versus Stented valve assessment by Echocardiography Randomized Trial) Investigators. Circulation. 2005;112:2696-2702.
58. Bortolotti U, Scioti G, Milano A, et al. The Edwards Prima stentless valve: hemodynamic performance at one year. Ann Thorac Surg. 1999;68:2147-2151.
59. Bach DS, Cartier PC, Kon ND, et al. Impact of implant technique following Freestyle stentless aortic valve replacement. Ann Thorac Surg. 2002;74:1107-1113.
60. Narang S, Satsangi K, Banerjee A, et al. Stentless valves versus stented bioprostheses at the aortic position: midterm results. J Thorac Cardiovasc Surg. 2008;136:943-947.
61. Doss M, Wood MJP, Aybek T, et al. Performance of stentless versus stented aortic valve prostheses in the elderly patients. A prospective randomized trial. Eur J Cardio Thorac Surg. 2003;23:299-304.
62. Risteski PS, Martens S, Rouhollahpour A, et al. Prospective randomized evaluation of stentless vs. stented aortic bioprosthetic valves in the elderly at five years. Inteactive Cardiovasc Thortac Surg. 2009;8: 449-453.
63. De Paulis R, Sommariva L, Colagrande L, et al. Regression of left ventricular hypertrophy after aortic valve replacement for aortic stenosis with different valve substitutes. J Thorac Cardiovasc Surg. 1998;116: 590-598.
64. Silberman S, Shaheen J, Merin O, et al. Exercise hemodynamics of aortic prostheses: comparison between stentless bioprostheses and mechanical valves. Ann Thorac Surg. 2001;72:1217-1221.
65. Walther T, Falk V, Langebartels G, et al. Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Circulation. 1999;101(Suppl II):II6-II0.
66. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072-1080.
67. Aupart MR, Mirza A, Meurisse YA, et al. Perimount pericardial bioprosthesis for aortic calcified stenosis. J Heart Valve Dis. 2006;15: 768-776.
68. Mohammadi S, Baillot R, Voisine P, et al. Structural deterioration of the Freestyle aortic valve: mode of presentation and mechanism. J Thorac Cardiovasc Surg. 2006;132:401-406.
69. Machida H, Ishibashi-Ueda H, Nakano K, et al. A morphological study of Carpentier-Edwards pericardial xenografts in the mitral position exhibiting primary tissue failure in adults in comparison with Ionescu-Shiley pericardial xenografts. J Thorac Cardiovasc Surg. 2001;122: 649-655.
70. Pavoni D, Badano LP, Ius F, et al. Limited long-term durability of the Cryolife O'Brien stentless porcine xenograft valve. Circulation. 2007;116(Suppl I):I307-I313.
71. Carrel TP, Schoenhoff FS, Schmidili J, et al. Deleterious outcome of No React-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136:52-57.
72. El-Hamamsy I, Zaki M, Stevens LM, et al. Rate of progression and functional significance of aortic root calcification after homograft versus Freestyle aortic root replacement. Circulation. 2009; 120(Suppl 1):S269-S275.
73. Hagl C, Galla JD, Lansman SL, et al. Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated? Ann Thorac Surg. 2002;74:S1781-S1785.
74. Müller LC, Chevtchik O, Bonatti JO, et al. Treatment of destructive aortic valve endocarditis with the Freestyle aortic root bioprosthesis. Ann Thorac Surg. 2003;75:453-456.
75. Siniawski H, Lehmkuhl H, Weng Y, et al. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg. 2003;75: 803-808.
76. Perrotta S, Lentini S. In patients with severe active aortic valve endocarditis, is a stentless valve as good as homograft? Interactive Cardiovasc Thorac Surg. 2010;11:309-313.
77. Halees ZA, Shahid MA, Sanei AA, et al. Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve? Eur J Cardio Thorac Surg. 2005;28:200-205.